-
Je něco špatně v tomto záznamu ?
Correction of aberrant splicing of ELP1 pre-mRNA by kinetin derivatives - A structure activity relationship study
B. Maková, V. Mik, B. Lišková, L. Drašarová, M. Medvedíková, A. Hořínková, P. Vojta, M. Zatloukal, L. Plíhalová, M. Hönig, K. Doležal, K. Forejt, T. Oždian, M. Hajdúch, M. Strnad, J. Voller
Jazyk angličtina Země Francie
Typ dokumentu časopisecké články
- MeSH
- kinetin * farmakologie chemie MeSH
- lidé MeSH
- molekulární struktura MeSH
- prekurzory RNA * genetika metabolismus MeSH
- sestřih RNA * účinky léků MeSH
- transkripční elongační faktory metabolismus genetika MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Familial dysautonomia is a debilitating congenital neurodegenerative disorder with no causative therapy. It is caused by a homozygous mutation in ELP1 gene, resulting in the production of the transcript lacking exon 20. The compounds studied as potential treatments include the clinical candidate kinetin, a plant hormone from the cytokinin family. We explored the relationship between the structure of a set of kinetin derivatives (N = 72) and their ability to correct aberrant splicing of the ELP1 gene. Active compounds can be obtained by the substitution of the purine ring with chlorine and fluorine at the C2 atom, with a small alkyl group at the N7 atom, or with diverse groups at the C8 atom. On the other hand, a substitution at the N3 or N9 atoms resulted in a loss of activity. We successfully tested a hypothesis inspired by the remarkable tolerance of the position C8 to substitution, postulating that the imidazole of the purine moiety is not required for the activity. We also evaluated the activity of phytohormones from other families, but none of them corrected ELP1 mRNA aberrant splicing. A panel of in vitro ADME assays, including evaluation of transport across model barriers, stability in plasma and in the presence of liver microsomal fraction as well as plasma protein binding, was used for an initial estimation of the potential bioavailability of the active compounds. Finally, a RNA-seq data suggest that 8-aminokinetin modulates expression spliceosome components.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25009871
- 003
- CZ-PrNML
- 005
- 20250429134607.0
- 007
- ta
- 008
- 250415e20241217fr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ejmech.2024.117176 $2 doi
- 035 __
- $a (PubMed)39756144
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a fr
- 100 1_
- $a Maková, Barbara $u Laboratory of Experimental Biology, Faculty of Science, Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic
- 245 10
- $a Correction of aberrant splicing of ELP1 pre-mRNA by kinetin derivatives - A structure activity relationship study / $c B. Maková, V. Mik, B. Lišková, L. Drašarová, M. Medvedíková, A. Hořínková, P. Vojta, M. Zatloukal, L. Plíhalová, M. Hönig, K. Doležal, K. Forejt, T. Oždian, M. Hajdúch, M. Strnad, J. Voller
- 520 9_
- $a Familial dysautonomia is a debilitating congenital neurodegenerative disorder with no causative therapy. It is caused by a homozygous mutation in ELP1 gene, resulting in the production of the transcript lacking exon 20. The compounds studied as potential treatments include the clinical candidate kinetin, a plant hormone from the cytokinin family. We explored the relationship between the structure of a set of kinetin derivatives (N = 72) and their ability to correct aberrant splicing of the ELP1 gene. Active compounds can be obtained by the substitution of the purine ring with chlorine and fluorine at the C2 atom, with a small alkyl group at the N7 atom, or with diverse groups at the C8 atom. On the other hand, a substitution at the N3 or N9 atoms resulted in a loss of activity. We successfully tested a hypothesis inspired by the remarkable tolerance of the position C8 to substitution, postulating that the imidazole of the purine moiety is not required for the activity. We also evaluated the activity of phytohormones from other families, but none of them corrected ELP1 mRNA aberrant splicing. A panel of in vitro ADME assays, including evaluation of transport across model barriers, stability in plasma and in the presence of liver microsomal fraction as well as plasma protein binding, was used for an initial estimation of the potential bioavailability of the active compounds. Finally, a RNA-seq data suggest that 8-aminokinetin modulates expression spliceosome components.
- 650 12
- $a kinetin $x farmakologie $x chemie $7 D007701
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a prekurzory RNA $x genetika $x metabolismus $7 D012322
- 650 12
- $a sestřih RNA $x účinky léků $7 D012326
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a transkripční elongační faktory $x metabolismus $x genetika $7 D035602
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Mik, Václav $u Laboratory of Experimental Biology, Faculty of Science, Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic
- 700 1_
- $a Lišková, Barbora $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 775 15 Olomouc, Czech Republic
- 700 1_
- $a Drašarová, Lenka $u Isotope Laboratory, Institute of Experimental Botany, Academy of Sciences of the Czech Republic, Vídeňská 1083, 142 00 Prague 4, Czech Republic
- 700 1_
- $a Medvedíková, Martina $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 775 15 Olomouc, Czech Republic
- 700 1_
- $a Hořínková, Alena $u Laboratory of Experimental Biology, Faculty of Science, Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic
- 700 1_
- $a Vojta, Petr $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 775 15 Olomouc, Czech Republic; University of Natural Resources and Life Sciences, Vienna, Department of Biotechnology, Institute of Computational Biology, Vienna, Austria
- 700 1_
- $a Zatloukal, Marek $u Department of Chemical Biology, Faculty of Science, Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic
- 700 1_
- $a Plíhalová, Lucie $u Department of Chemical Biology, Faculty of Science, Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic
- 700 1_
- $a Hönig, Martin $u Department of Chemical Biology, Faculty of Science, Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic
- 700 1_
- $a Doležal, Karel $u Department of Chemical Biology, Faculty of Science, Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic; Laboratory of Growth Regulators, Institute of Experimental Botany AS CR & Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic
- 700 1_
- $a Forejt, Kristýna $u Laboratory of Experimental Biology, Faculty of Science, Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic
- 700 1_
- $a Oždian, Tomáš $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 775 15 Olomouc, Czech Republic
- 700 1_
- $a Hajdúch, Marián $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 775 15 Olomouc, Czech Republic
- 700 1_
- $a Strnad, Miroslav $u Laboratory of Growth Regulators, Institute of Experimental Botany AS CR & Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic
- 700 1_
- $a Voller, Jiří $u Laboratory of Experimental Biology, Faculty of Science, Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 775 15 Olomouc, Czech Republic. Electronic address: jiri.voller@upol.cz
- 773 0_
- $w MED00001628 $t European journal of medicinal chemistry $x 1768-3254 $g Roč. 284 (20241217), s. 117176
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39756144 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429134603 $b ABA008
- 999 __
- $a ok $b bmc $g 2311326 $s 1246952
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 284 $c - $d 117176 $e 20241217 $i 1768-3254 $m European journal of medicinal chemistry $n Eur J Med Chem $x MED00001628
- LZP __
- $a Pubmed-20250415